A detailed history of Novare Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Novare Capital Management LLC holds 527 shares of LLY stock, worth $431,576. This represents 0.04% of its overall portfolio holdings.

Number of Shares
527
Previous 302 74.5%
Holding current value
$431,576
Previous $273,000 70.7%
% of portfolio
0.04%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$772.14 - $960.02 $173,731 - $216,004
225 Added 74.5%
527 $466,000
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $8,698 - $10,908
-12 Reduced 3.82%
302 $273,000
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $185,950 - $248,775
314 New
314 $244,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Novare Capital Management LLC Portfolio

Follow Novare Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novare Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Novare Capital Management LLC with notifications on news.